Pyxus International, Inc. Reports First Quarter Fiscal 2027 Results
"During the quarter, we leveraged current market conditions to execute a more selective approach within our demand-led sourcing model. We procured higher-quality tobacco at lower costs, strengthening our ability to meet customer requirements as shipment volumes increase over the balance of the year."
First Quarter Fiscal 2027 Results
First quarter sales and other operating revenues decreased to
Cost of goods and services sold for the first quarter of fiscal 2027 decreased
Gross profit was down
Income tax (benefit) expense decreased
The Company's operating income for the first quarter was
Select Balance Sheet and Liquidity Information
The first quarter of our fiscal year typically represents a seasonally high investment for purchases of green tobacco. However, our total leaf tobacco inventories decreased
As of
Uncommitted inventory as a percentage of total processed tobacco has increased compared to a year ago, which is to be expected as supply and demand shifts evolve in the global tobacco market environment. At
The Company's average operating cycle time was 173 days in the first quarter compared to 160 days in the same period last fiscal year. The 13-day increase is primarily from higher carry-over of processed tobacco in
Maintains Guidance for Fiscal Year
The Company maintains its full-year fiscal 2027 guidance, with expected net sales of
Financial Results Investor Call
The Company will hold an earnings conference call and webcast on
This release, as well as the Company's first quarter results presentation, will be available on the Company's investor relations webpage prior to the call. For those unable to join the live audio webcast, an archived recording will be available on the Company's investor relations webpage shortly after the call.
Any replay, rebroadcast, transcript, or other reproduction of this conference call, other than the replay accessible by calling the number above, has not been authorized by Pyxus and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.
Cautionary Statement Regarding Forward-Looking Statements
Readers are cautioned that the statements contained in this report regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are based on current expectations of future events, may be identified by the use of words such as "guidance", "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," and other words of similar meaning. These statements also may be identified by the fact that they do not relate strictly to historical or current facts. If underlying assumptions prove inaccurate, or if known or unknown risks or uncertainties materialize, actual results could vary materially from those anticipated, estimated, or projected. These risks and uncertainties include those discussed in our Annual Report on Form 10-K for the year ended
Non-GAAP Financial Information
This press release contains financial measures that have not been prepared in accordance with generally accepted accounting principles in
About Pyxus International, Inc.
Pyxus International, Inc. is a global agricultural company with more than 150 years of experience delivering value-added products and services to businesses and customers. Driven by a united purpose—to transform people's lives, so that together we can grow a better world—Pyxus International, its subsidiaries and affiliates, are trusted providers of responsibly sourced, independently verified, sustainable and traceable products and ingredients.
Condensed Consolidated Statements of Operations Information | ||
Three Months Ended | ||
(in thousands, except per share data) | 2026 | 2025 |
Sales and other operating revenues | $ 437,795 | $ 508,815 |
Cost of goods and services sold | 376,381 | 443,189 |
Gross profit | 61,414 | 65,626 |
Gross profit as a percent of sales | 14.0 % | 12.9 % |
Selling, general, and administrative expenses | 43,935 | 40,369 |
Other expense, net | 1,257 | 4,176 |
Restructuring and asset impairment charges | 557 | 81 |
Operating income | 15,665 | 21,000 |
Interest expense, net | 29,842 | 29,767 |
Loss before income taxes and other items | (14,177) | (8,767) |
Income tax (benefit) expense | (5,716) | 5,227 |
Income (loss) from unconsolidated affiliates, net | 1,422 | (1,269) |
Net loss | (7,039) | (15,263) |
Net income attributable to noncontrolling interests | 241 | 562 |
Net loss attributable to Pyxus International, Inc. | $ (7,280) | $ (15,825) |
Loss per share: | ||
Basic | $ (0.28) | $ (0.62) |
Diluted | $ (0.28) | $ (0.62) |
Weighted average number of shares outstanding: | ||
Basic | 26,056 | 25,670 |
Diluted | 26,056 | 25,670 |
Condensed Consolidated Balance Sheets | |||||
(in thousands) | |||||
Assets | |||||
Current assets | |||||
Cash and cash equivalents | $ 175,907 | $ 96,437 | |||
Restricted cash | 3,642 | 4,945 | |||
Trade receivables, net | 175,667 | 206,607 | |||
Other receivables | 10,897 | 16,683 | |||
Inventories, net | 1,104,637 | 1,121,788 | |||
Advances to tobacco suppliers, net | 88,132 | 61,737 | |||
Recoverable income taxes | 14,366 | 11,670 | |||
Prepaid expenses | 59,366 | 50,011 | |||
Other current assets | 20,334 | 21,123 | |||
Total current assets | 1,652,948 | 1,591,001 | |||
Investments in unconsolidated affiliates | 96,174 | 95,659 | |||
Intangible assets, net | 22,984 | 27,387 | |||
Deferred income taxes, net | 14,620 | 13,181 | |||
Long-term recoverable income taxes | 10,157 | 4,956 | |||
Other noncurrent assets | 44,082 | 39,315 | |||
Right-of-use assets | 34,858 | 32,033 | |||
Property, plant, and equipment, net | 141,431 | 136,993 | |||
Total assets | $ 2,017,254 | $ 1,940,525 | |||
Liabilities and Stockholders' Equity | |||||
Current liabilities | |||||
Notes payable | $ 828,553 | $ 880,925 | |||
Accounts payable | 114,644 | 124,341 | |||
Advances from customers | 166,718 | 87,374 | |||
Accrued expenses and other current liabilities | 131,506 | 104,162 | |||
Income taxes payable | 10,838 | 10,449 | |||
Operating leases payable | 10,064 | 9,565 | |||
Total current liabilities | 1,262,323 | 1,216,816 | |||
Long-term taxes payable | 4,807 | 6,195 | |||
Long-term debt | 456,020 | 455,091 | |||
Deferred income taxes | 8,128 | 8,902 | |||
Liability for unrecognized tax benefits | 29,507 | 21,935 | |||
Long-term leases | 22,044 | 19,541 | |||
Pension, postretirement, and other long-term liabilities | 59,600 | 57,805 | |||
Total liabilities | $ 1,842,429 | $ 1,786,285 | |||
Commitments and contingencies | |||||
Stockholders' equity | |||||
Common Stock—no par value: | |||||
Authorized shares (250,000 for all periods) | |||||
Issued and outstanding shares (24,608 for all periods) | $ 394,203 | $ 393,136 | |||
Retained deficit | (232,836) | (255,950) | |||
Accumulated other comprehensive income | 6,598 | 10,811 | |||
Total stockholders' equity of Pyxus International, Inc. | 167,965 | 147,997 | |||
Noncontrolling interests | 6,860 | 6,243 | |||
Total stockholders' equity | 174,825 | 154,240 | |||
Total liabilities and stockholders' equity | $ 2,017,254 | $ 1,940,525 | |||
Segment Results | ||||
Three Months Ended | ||||
Three Months Ended | ||||
Change | ||||
(in millions, except per kilo amounts) | 2026 | 2025 | $ | % |
Leaf: | ||||
Product revenues | $ 393.0 | $ 458.2 | (65.2) | (14.2) |
Tobacco costs | 316.9 | 375.7 | (58.8) | (15.7) |
Transportation, storage, and other period costs | 22.6 | 25.1 | (2.5) | (10.0) |
Total product cost of goods sold | 339.5 | 400.8 | (61.3) | (15.3) |
Product gross profit | 53.5 | 57.4 | (3.9) | (6.8) |
Product gross profit as a percent of sales | 13.6 % | 12.5 % | ||
Kilos sold | 63.5 | 66.9 | (3.4) | (5.1) |
Average price per kilo | $ 6.19 | $ 6.85 | (0.66) | (9.6) |
Average cost per kilo | 5.35 | 5.99 | (0.64) | (10.7) |
Average gross profit per kilo | 0.84 | 0.86 | (0.02) | (2.3) |
Processing and other revenues | $ 42.8 | $ 50.2 | (7.4) | (14.7) |
Processing and other costs of services sold | 36.2 | 42.6 | (6.4) | (15.0) |
Processing and other gross profit | 6.6 | 7.6 | (1.0) | (13.2) |
Processing and other gross profit as a percent of sales | 15.4 % | 15.1 % | ||
All Other: | ||||
Sales and other operating revenues | $ 2.0 | $ 0.4 | 1.6 | 400.0 |
Cost of goods and services sold | 0.7 | (0.2) | 0.9 | 450.0 |
Gross profit | 1.3 | 0.6 | 0.7 | 116.7 |
Gross profit as a percent of sales | 65.0 % | 150.0 % | ||
Reconciliation of Certain Non-GAAP Financial Measures (1) (Unaudited) | |||||||
Three Months Ended | Fiscal Year Ended | Last Twelve Months (4) | |||||
(in thousands) |
|
| |||||
Net (loss) income attributable to Pyxus International, Inc. | $ (7,280) | $ (15,825) | $ 4,642 | $ 14,569 | $ 15,166 | 23,114 | $ (5,301) |
Plus: Interest expense | 31,043 | 30,623 | 34,475 | 138,749 | 133,108 | 139,169 | 129,256 |
Plus: Income tax (benefit) expense | (5,716) | 5,227 | 6,119 | 30,344 | 25,053 | 19,401 | 24,161 |
Plus: Depreciation and amortization expense | 5,628 | 5,169 | 5,127 | 20,893 | 20,334 | 21,352 | 20,376 |
EBITDA (1) | 23,675 | 25,194 | 50,363 | 204,555 | 193,661 | 203,036 | 168,492 |
Plus: (Recoveries) reserves for doubtful customer receivables | (251) | (226) | 157 | (648) | 103 | (673) | (280) |
Plus: Noncash equity-based compensation | 282 | 237 | 3,031 | 1,022 | 4,110 | 1,067 | 1,316 |
Plus: Other expense, net | 1,257 | 4,176 | 2,630 | 18,910 | 16,410 | 15,991 | 17,956 |
Plus: Restructuring and asset impairment charges | 557 | 81 | 103 | 2,852 | 2,259 | 3,328 | 2,237 |
Less: Gain on debt retirement | — | — | 1,323 | — | 8,178 | — | 6,855 |
Plus: Other adjustments (2) | 2,226 | (11) | 9 | (26) | 45 | 2,211 | 25 |
Adjusted EBITDA (1) | $ 27,746 | $ 29,451 | $ 54,970 | $ 226,665 | $ 208,410 | $ 224,960 | $ 182,891 |
Total debt | $ 932,889 | $ 849,892 | $ 1,284,573 | $ 1,336,016 | |||
Less: Cash and cash equivalents | 134,337 | 78,254 | 175,907 | 96,437 | |||
Net Debt (1) | $ 798,552 | $ 771,638 | $ 1,108,666 | $ 1,239,579 | |||
Net Debt /Adjusted EBITDA (1) | 3.52x | 3.70x | 4.93x | 6.78x | |||
Adjusted EBITDA (1) | $ 226,665 | $ 208,410 | $ 224,960 | $ 182,891 | |||
Interest expense | 138,749 | 133,108 | 139,169 | 129,256 | |||
Interest coverage | 1.63x | 1.57x | 1.62x | 1.41x | |||
Net cash used in operating activities | $ (359,708) | $ (495,287) | $ (252,176) | $ (208,451) | $ (13,386) | $ (72,872) | $ (256,497) |
Capital expenditures | (4,186) | (4,279) | (5,097) | (22,051) | (23,028) | (21,958) | (22,210) |
Collections from beneficial interests in securitized trade receivables (3) | 58,540 | 41,007 | 31,741 | 200,684 | 188,312 | 218,217 | 197,578 |
Adjusted Free Cash Flow (1) | $ (305,354) | $ (458,559) | $ (225,532) | $ (29,818) | $ 151,898 | $ 123,387 | $ (81,129) |
(1) | Earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"), Adjusted Free Cash Flow, and Net Debt are not measures of results of operations, cash flows from operations or indebtedness under generally accepted accounting principles in |
(2) | Includes other individually insignificant adjustments that are not reflective of the Company's ongoing operations. |
(3) | Represents cash receipts from the beneficial interest on sold receivables under the Company's accounts receivable securitization programs and are classified as investing activities within the condensed consolidated statements of cash flows. |
(4) | Items for the twelve months ended |
View original content to download multimedia:https://www.prnewswire.com/news-releases/pyxus-international-inc-reports-first-quarter-fiscal-2027-results-302843108.html
SOURCE Pyxus International, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- REAL ESTATE INVESTOR OPTIMISM DIPS TO RECORD LOW ACCORDING TO SUMMER 2026 RCN CAPITAL INVESTOR SENTIMENT SURVEY
- Jumex Enters the Protein Category with 30g of Protein, Rooted in Authentic Mexican Heritage and Innovative Mexican-Inspired Flavors.
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share